Showing results (31-40 of 99) with videos related to
Sort By:
Pageof 10
Neuroepidemiology|January 1, 1989
On the estimation of the distribution of the latent period of multiple sclerosisC Wolfson, D B Wolfson, J M ZielinskiNeuroepidemiology|June 5, 2009
Incidence and prevalence of amyotrophic lateral sclerosis in Canada: a systematic review of the literatureC Wolfson, S Kilborn, M Oskoui, et al.BMC Geriatrics|December 14, 2001
High daily doses of benzodiazepines among Quebec seniors: prevalence and correlatesM Y Egan, C Wolfson, Y Moride, et al.Pathology|August 1, 1996
Prevalence of Bartonella henselae bacteremia, the causative agent of cat scratch disease, in an Australian cat populationJ Branley, C Wolfson, P Waters, et al.Journal of Geriatric Psychiatry and Neurology|December 29, 2000
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of functional and quality of life scalesL Demers, M Oremus, A Perrault, et al.Neuroepidemiology|January 1, 1993
Multiple sclerosis: a comparison of the latent periods of different populationsC Wolfson, D B Wolfson, J P Veri, et al.Journal of the American Geriatrics Society|October 16, 1999
Predictors of five-year mortality in older Canadians: the Canadian Study of Health and AgingT Ostbye, R Steenhuis, C Wolfson, et al.Journal of Geriatric Psychiatry and Neurology|December 29, 2000
Review of outcome measurement instruments in Alzheimer's disease drug trials: psychometric properties of behavior and mood scalesA Perrault, M Oremus, L Demers, et al.Health Reports|January 30, 2010
Income disparities in health-adjusted life expectancy for Canadian adults, 1991 to 2001Cameron N McIntosh, Philippe Finès, Russell Wilkins, et al.Epidemiology (Cambridge, Mass.)|July 1, 1996
Organic solvents and multiple sclerosis: a synthesis of the current evidenceA M Landtblom, U Flodin, B Söderfeldt, et al.Pageof 10